85-1527-03　Regadenoson (2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine) 2.5mg　R1375

特徴

• Regadenoson is a selective and potent A2A adenosine receptor agonist (1). The adenosine A2A receptor is a G-protein-coupled receptor and a key therapeutic target for oncologic, inflammatory, Parkinson’s and cardiovascular diseases (2). In rodent studies, it has been shown that co-administration of Regadenoson with Temozolomide can increase Temozolomide concentration in the brain (3).
• Synonyms:2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine
• Molecular Formula:C15H18N8O5
• Molecular Weight:390.35
• Appearance:White to Pale Beige Solid
• Purity:≥98%
• Melting Point:194-196˚C
• Solubility:DMSO (Slightly), Methanol (Slightly, Sonicated)
• Method for Determining Identity:Proton NMR Spectroscopic Analysis
• TLC Conditions:As reported
• Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Store under inert stmosphere.